Financials Torrent Pharmaceuticals Limited

Equities

TORNTPHARM

INE685A01028

Pharmaceuticals

Market Closed - Bombay S.E. 03:30:52 24/06/2024 pm IST 5-day change 1st Jan Change
2,839 INR +0.29% Intraday chart for Torrent Pharmaceuticals Limited -1.65% +23.15%

Valuation

Fiscal Period: March 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 3,30,355 3,33,623 4,30,029 4,73,197 5,20,309 9,57,987 - -
Enterprise Value (EV) 1 3,66,505 3,87,633 4,58,139 5,08,027 5,66,719 9,10,767 9,79,519 9,66,407
P/E ratio 75.7 x 32.6 x 34.3 x 60.9 x 57.4 x 53.1 x 46.9 x 36.6 x
Yield 0.87% 0.86% 1.38% 1.18% 1.43% 1.08% 0.88% 1.02%
Capitalization / Revenue 4.31 x 4.2 x 5.37 x 5.56 x 5.41 x 8.21 x 7.92 x 7.01 x
EV / Revenue 4.78 x 4.88 x 5.72 x 5.97 x 5.89 x 8.49 x 8.1 x 7.08 x
EV / EBITDA 18.5 x 17.9 x 18.4 x 20.9 x 19.9 x 27 x 25.1 x 21.2 x
EV / FCF 32.3 x 39.3 x 27.3 x 31.8 x 31.6 x 32.1 x 43.2 x 32.4 x
FCF Yield 3.1% 2.54% 3.66% 3.15% 3.17% 3.11% 2.32% 3.08%
Price to Book 6.99 x 6.92 x 7.4 x 7.95 x 8.4 x 12.8 x 12 x 9.97 x
Nbr of stocks (in thousands) 3,38,444 3,38,445 3,38,445 3,38,445 3,38,445 3,38,445 - -
Reference price 2 976.1 985.8 1,271 1,398 1,537 2,831 2,831 2,831
Announcement Date 20/05/19 26/05/20 18/05/21 25/05/22 30/05/23 24/05/24 - -
1INR in Million2INR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 76,730 79,390 80,050 85,080 96,200 1,07,280 1,20,956 1,36,565
EBITDA 1 19,840 21,700 24,850 24,310 28,420 33,680 39,092 45,516
EBIT 1 13,660 15,160 18,270 17,690 21,350 26,480 30,700 37,001
Operating Margin 17.8% 19.1% 22.82% 20.79% 22.19% 24.68% 25.38% 27.09%
Earnings before Tax (EBT) 1 5,620 11,870 15,260 12,260 18,470 23,520 28,926 36,012
Net income 1 4,360 10,250 12,520 7,770 12,450 16,560 20,426 26,110
Net margin 5.68% 12.91% 15.64% 9.13% 12.94% 15.44% 16.89% 19.12%
EPS 2 12.89 30.28 36.99 22.96 26.79 48.94 60.30 77.26
Free Cash Flow 1 11,352 9,860 16,760 16,000 17,940 28,330 22,693 29,793
FCF margin 14.8% 12.42% 20.94% 18.81% 18.65% 26.41% 18.76% 21.82%
FCF Conversion (EBITDA) 57.22% 45.44% 67.44% 65.82% 63.12% 84.12% 58.05% 65.46%
FCF Conversion (Net income) 260.38% 96.2% 133.87% 205.92% 144.1% 171.07% 111.1% 114.11%
Dividend per Share 2 8.500 8.500 17.50 16.50 22.00 28.00 24.91 28.85
Announcement Date 20/05/19 26/05/20 18/05/21 25/05/22 30/05/23 24/05/24 - -
1INR in Million2INR
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: March 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 19,950 19,370 21,340 21,370 21,080 21,310 23,470 22,910 24,910 24,910 25,910 26,329 27,505 27,836 29,207
EBITDA 1 6,070 5,820 6,770 6,600 5,380 5,610 7,120 6,790 7,240 7,270 7,910 8,124 8,597 8,895 9,297
EBIT 1 4,400 4,170 5,120 4,920 3,710 3,990 5,570 5,160 5,310 5,310 6,000 6,087 6,507 6,782 7,093
Operating Margin 22.06% 21.53% 23.99% 23.02% 17.6% 18.72% 23.73% 22.52% 21.32% 21.32% 23.16% 23.12% 23.66% 24.37% 24.29%
Earnings before Tax (EBT) 1 3,570 3,830 4,840 4,720 3,570 -870 5,320 4,630 4,190 4,330 5,310 5,592 6,014 6,426 6,555
Net income 1 2,970 3,240 3,300 3,160 2,490 -1,180 3,540 3,120 2,830 2,870 3,780 3,892 4,173 4,570 4,588
Net margin 14.89% 16.73% 15.46% 14.79% 11.81% -5.54% 15.08% 13.62% 11.36% 11.52% 14.59% 14.78% 15.17% 16.42% 15.71%
EPS 2 8.760 9.580 9.765 9.315 7.375 -3.490 20.90 9.220 8.360 8.480 11.18 11.43 12.51 13.23 13.60
Dividend per Share - - - - - - - - - - - - - - -
Announcement Date 08/02/21 18/05/21 27/07/21 26/10/21 25/01/22 25/05/22 29/07/22 21/10/22 25/01/23 30/05/23 07/08/23 - - - -
1INR in Million2INR
Estimates

Balance Sheet Analysis

Fiscal Period: March 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 36,150 54,010 28,110 34,830 46,410 30,420 21,532 8,421
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 1.822 x 2.489 x 1.131 x 1.433 x 1.633 x 0.9032 x 0.5508 x 0.185 x
Free Cash Flow 1 11,353 9,860 16,760 16,000 17,940 28,330 22,693 29,793
ROE (net income / shareholders' equity) 15.4% 21.5% 23.5% 13.2% 20.5% 25.4% 27.3% 29.2%
ROA (Net income/ Total Assets) 5.06% 7.28% 8.92% 5.72% 8.86% 11% 13.6% 16.1%
Assets 1 86,166 1,40,795 1,40,425 1,35,875 1,40,560 1,50,365 1,49,980 1,62,651
Book Value Per Share 2 140.0 142.0 172.0 176.0 183.0 203.0 236.0 284.0
Cash Flow per Share 2 53.20 41.10 59.40 53.30 51.00 96.50 61.80 73.60
Capex 1 6,628 4,060 3,350 2,030 5,740 4,330 3,452 3,551
Capex / Sales 8.64% 5.11% 4.18% 2.39% 5.97% 4.04% 2.85% 2.6%
Announcement Date 20/05/19 26/05/20 18/05/21 25/05/22 30/05/23 24/05/24 - -
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
30
Last Close Price
2,831 INR
Average target price
2,876 INR
Spread / Average Target
+1.59%
Consensus
  1. Stock Market
  2. Equities
  3. TORNTPHARM Stock
  4. Financials Torrent Pharmaceuticals Limited